Brooklyn, New York Clinical Trials

A listing of Brooklyn, New York clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 517 clinical trials
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

This is a Phase 2 study designed to determine the preliminary anti-tumor activity and confirm the safety of VV1 in combination with cemiplimab. The study will concurrently enroll patients with four distinct advanced malignancies in 5 separate tumor cohorts. The four cancers type are NSCLC and melanoma that are progressing …

metastasis
sorafenib
adenocarcinoma
endometrioid adenocarcinoma of the endometrium
ipilimumab
Icahn School of Medicine at Mount Sinai
 (7.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +8 other locations
A Study to Evaluate the Safety Pharmacokinetics and Activity of GDC-6036 in Patients With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation

This is a Phase I dose-escalation and dose-expansion study that will evaluate the safety, pharmacokinetics (PK), and preliminary activity of GDC-6036 in patients with advanced or metastatic solid tumors with a KRAS G12C mutation.

metastatic malignant solid tumor
ki-ras
kras g12c mutation
solid tumour
kras
Memorial Sloan Kettering Cancer Center
 (5.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +7 other locations
Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma

The purpose of this study is to find out whether acupuncture treatments can reduce the need for opioid medication when managing pain caused by chemotherapy. The study will compare the effects of adding acupuncture to usual pain management with those of usual pain management alone, in reducing opioid use by …

pain management
lymphoma
multiple myeloma
acupuncture
cancer
Memorial Sloan Kettering Cancer Center
 (5.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +1 other locations
The Young Heart Study

The purpose of our project is to better understand the characteristics of the young patients with coronary artery disease presenting for cardiac catheterization at our institution and to put forth a program to optimize their risk factors with a focus on gender differences. We will assess traditional and non-traditional risk …

anxiety
depression
arterial disease
atherosclerosis
cardiovascular disease
Lenox Hill Hospital
 (5.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Study of AK104 a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer

This is a Phase 2, global, multicenter, open label, single arm study designed to evaluate the efficacy, safety, tolerability, pharmacokinetic (PK), and immunogenicity of AK104 monotherapy in adult subjects with previously treated recurrent or metastatic cervical carcinoma.

cervical carcinoma
metastasis
attenuated vaccines
prednisone
immunosuppressive
The Blavatnik Family - Chelsea Medical Center at Mount Sinai
 (3.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +19 other locations
Double-Blind Multicenter Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19

This clinical trial will examine if a new treatment of Mesenchymal Stems Cells (called PLX-PAD) can help patients intubated and mechanically ventilated due to COVID-19 to recover more quickly with less complications.

acute respiratory distress
covid-19
SARS
respiratory distress
acute respiratory syndrome (sars)
Maimonides Medical Center
 (4.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +2 other locations
Study of CB-5339 in Acute Myeloid Leukemia or Myelodysplastic Syndrome

This is a multicenter, open-label Phase 1 study of orally administered CB-5339 in participants with R/R AML or participants with R/R intermediate- to high-risk MDS.

acute myeloid leukemia
remission
myeloid leukemia
gilbert's syndrome
cervical cap
Memorial Sloan Kettering Cancer Center
 (5.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +4 other locations
Assessing Minimal Residual Disease by Next- Generation Sequencing to Minimize Exposure in People With CLL or SLL Who Have Been Treated With Venetoclax

This study will find out whether people with CLL or SLL who have received treatment with venetoclax, either alone or in combination with another drug, and who are found to be MRD-negative, can stop treatment with venetoclax and remain off-treatment for 12 months or more. The researchers will also see …

residual tumor
remission
lymphoma
minimal residual disease
antibody therapy
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
 (5.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +9 other locations
Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

This is a Phase 1b/2, open-label, multicenter platform trial to evaluate the antitumor activity and safety of AB928-based combination therapy in participants with metastatic castrate resistant prostate cancer (mCRPC).

measurable disease
antiandrogens
antiandrogen therapy
enzalutamide
prostatic neoplasm
New York University, Langone Health
 (3.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +21 other locations
A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy

The researchers are doing this study to find out whether the study drug hydroxychloroquine can prevent infection with the COVID-19 virus, compared with placebo, in people who are receiving radiation therapy for their cancer. The placebo used in this study is a tablet that looks the same as the study …

chills
anosmia
pharyngitis
sore throat
nervous
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
 (5.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +6 other locations